Safety assessment of treatment with bevacizumab in metastatic colorectal cancer: an observational study.

Trial Profile

Safety assessment of treatment with bevacizumab in metastatic colorectal cancer: an observational study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jun 2014

At a glance

  • Drugs Bevacizumab (Primary) ; Antineoplastics
  • Indications Colorectal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Jan 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 16 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top